|
|
|
|
 |
|
|
|
|
Name |
Mebiopharm Co., Ltd. |
|
Established: |
July 15, 2002 |
|
Financed Amount: |
JPY 4,183.05M
| |
|
|
|
 CEO:
|
Mr. Tadashi
Fujisawa |
|
( Former GlaxoSmithKline
K.K.) |
|
|
|
Founder: |
Dr. Masazumi
Eriguchi |
|
(Former Professor,
Research Center for Advanced Science and Technology,
The University of Tokyo)
|
|
|
|
Founder: |
Dr. Hironobu
Yanagie |
|
(Specially Appointed
Associate Professor, School of Engineering,
The University of Tokyo)
|
|
|
|
Founder: |
Dr. Kazuo
Maruyama |
|
(Professor, Department of
Biopharmaceutics, School of Pharmaceutical
Sciences, Teikyo University)
|
|
|
|
|
|
|
|
|
|
|
Auditor: |
Mr. Ryoichi
Nishizawa |
|
(Certified Public Accountant,
Licensed Tax Accountant) |
| |
|
|
Advisor: |
Dr. Charles M.
Johnson, III, M.D., FACS,
FAAP |
|
(Private Practice:
Otolaryngology, Pediatric Otolaryngology, Head
and Neck Surgical Oncology and Otolaryngologic
Allergy, M.D., The Johns Hopkins
University) |
|
|
|
|
| |
|
|
| Mr. Tadashi
Fujisawa |
(Founder) |
| Dr. Masazumi Eriguchi |
(Former Professor,
Research Center for Advanced
Science and Technology, The University of Tokyo)
|
| Dr. Hironobu Yanagie |
(Specially Appointed Associate Professor,
School of Engineering,
The University of Tokyo) |
| JPMORGAN CHASE |
| |
|
| PHILLIP SECURITIES PTELTD
|
| Beijing Tide Pharmaceutical Co., Ltd. |
| CREDIT SUISSE SECURITIES(EUROPE) LIMITED
|
| Shinsei Bank , Limited
|
| Sumitomo Mitsui Banking Corporation
|
| PERSHING-DIV. OF DLJ SECS. CORP.
|
|
| | |
|
